Tessa Therapeutics

Based in Singapore, Tessa Therapeutics is a clinical-stage cell therapy company focused on developing autologous and off-the-shelf allogeneic therapies targeting a wide range of cancers. Tessa's Virus-Specific T cell (VST) platform harnesses the body's potent anti-viral immune response and has shown early efficacy and a strong safety profile in the treatment of solid tumors.